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The M2 protein of influenza A virus functions as an ion channel. It contains three cysteine residues: cysteines 17 and
19, which form disulfide bonds in the ectodomain, and cysteine 50, which is acylated. To understand the role of these
cysteine residues in virus replication, we used reverse genetics to create influenza viruses in which the individual cysteines
were mutated and a virus in which all three cysteines were changed to serine. The M2 cysteine mutants that lacked either
of the cysteine residues in the ectodomain and the mutant that lacked all three residues had appreciably lower amounts
of M2 oligomers than did the wild-type virus when examined by sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
None of the mutants, however, were defective in replication, either in vitro or in ferrets and mice. These findings demonstrate
that noncovalent interactions are sufficient for the M2 protein to form functional oligomers for virus replication and that its
cysteine residues are dispensable for influenza virus replication in vitro and in vivo. q 1997 Academic Press
INTRODUCTION (Sugrue and Hay, 1991; Holsinger and Lamb, 1991). Of
the three cysteine residues in most M2 proteins, Cys-17The matrix (M) gene of influenza A viruses encodes
and -19 are involved in the disulfide linkages and Cys-two proteins, M1 and M2 (Lamb, 1989). M2, an integral
50 is palmitylated (Holsinger and Lamb, 1991; Sugrue etmembrane protein (Zebedee and Lamb, 1988), is a homo-
al., 1990; Veit et al., 1991a). Because some strains lacktetramer (Holsinger and Lamb, 1991; Panayotov and
Cys-19, Cys-17 is considered sufficient for M2 disulfideSchlesinger, 1992; Sugrue and Hay, 1991) that is abun-
bond formation (Zebedee and Lamb, 1988). Site-specificdantly expressed at the surface of virus-infected cells
mutagenesis has demonstrated that although disulfidebut is a relatively minor component of virions (Zebedee
bond formation is not essential for oligomeric assembly,and Lamb, 1988). Sharing eight amino-terminal residues
it does stabilize the M2 tetramer (Holsinger and Lamb,with M1, the M2 protein comprises 97 amino acids—24
1991). A mutant tetramer that lacks both Cys-17 and Cys-form the ectodomain, 19 the transmembrane domain, and
19 was detected only with the use of a crosslinker, high-54 the cytoplasmic domain. M2 proteins are ion channels
lighting its instability under the conditions examined andwhich are believed to function during uncoating and to
raising the possibility that a virus with such mutationsmodulate intracellular pH. This pH modulation is essen-
may be inviable or attenuated. Because the M2 proteinstial to prevent the acid-induced conformational change
of some recent H3N8 equine strains are not palmitylated,of the intracellularly cleaved A/fowl plague/Rostock/34
owing to a substitution of Cys-50 with Phe (Sugrue et al.,(H7N1) HA in the trans-Golgi network (Hay et al., 1985;
1990), M2 palmitylation is apparently not essential forTakeuchi and Lamb, 1994; Ohuchi et al., 1994). The activ-
viral replication. However, the M2 protein of the H3N8ity of the M2 ion channel is blocked by the anti-influenza
virus is associated with a decrease in the proportion ofdrug amantadine hydrochloride (Hay et al., 1993).
oligomers compared with other strains under nonreduc-The M2 protein forms a homotetramer through the non-
ing conditions (Sugrue et al., 1990). This result suggestscovalent association of disulfide-linked M2 dimers
that M2 palmitylation affects the stability of M2 oligo-
mers. In addition, the absence of palmitate from the H3N81 Present address: Department of Pathobiological Sciences, School
virus M2 may be compensated for by other features ofof Veterinary Medicine, University of Wisconsin-Madison, 2015 Linden
Drive West, Madison, WI 53706. M2 or by other virus components. Finally, Holsinger et
2 To whom correspondence and reprint requests should be ad- al. (1995) found that none of the three cysteine residues
dressed at present address: Department of Pathobiological Sciences, in M2 were required for ion channel activity tested in theSchool of Veterinary Medicine, University of Wisconsin-Madison, 2015
oocyte system. Thus, the aim of this study is to directlyLinden Drive West, Madison, WI 53706. Fax: (608) 265-5622. E-mail:
kawaokay@svm.vetmed.wisc.edu. analyze the role of the M2 cysteine residues in virus
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replication by generating transfectant viruses in which ster, 1992), to confirm the origin of the gene and to ensure
these residues are substituted with serine residues. that only the intended mutations had been created. All
but the Cys-50 mutant virus stocks contained only the M
gene that originated from the transfected RNP. The Cys-MATERIALS AND METHODS
50 mutant had the M gene of Eq/MIA as well as the
Viruses and cells. Influenza A/equine/Miami/63 (H3N8) transfected gene, as detected by nucleotide sequencing.
(Eq/MIA), A/Puerto Rico/8/34 (H1N1) (PR8), A/Udorn/302/ We therefore plaque-purified the Cys-50 mutant three
72 (H3N2), and A/duck/Alberta/35/76 (H1N1) viruses more times in MDCK cells in the presence of amantadine
were obtained from a repository at St. Jude Children’s under conditions where only a single plaque is detected
Research Hospital. The Madin–Darby bovine kidney per 3-cm petri dish. A final plaque was inoculated into
(MDBK) and Vero cell lines were cultured in Eagle’s mini- eggs to make a stock virus that did not contain detectable
mal essential medium (MEM) containing 10% fetal calf amounts of the Eq/MIA M gene.
serum. Madin–Darby canine kidney (MDCK) cells were Experimental infection. We anesthetized 5-month-old
cultured under the same conditions as MDBK cells, ex- ferrets (three per group; Marshall Farms, North Rose, NY)
cept that 5% calf serum was used. with ketamine-HCl (50 mg) intramuscularly and infected
Reverse genetics. A plasmid (pPR8M-10) containing them intranasally with 1 ml of virus [approximately 107
the PR8 M gene was constructed as described by Hud- plaque-forming units (PFU)]. The animals’ nostrils were
dleston and Brownlee (1982). A second plasmid washed out with 1 ml of phosphate-buffered saline (PBS),
(pUCT3PRM), containing the PR8 M gene flanked by the pH 7.2, and the virus in the nasal wash samples was
Ksp632I site and the T3 RNA polymerase promoter se- titrated with MDCK cells. Six-week-old female Balb/c
quence, was cloned by PCR (Saiki et al., 1988) using the mice, anesthetized with methoxyflurane, were infected
pPR8M-10 as a template and the following primers: 5*- intranasally with 50 ml (107 PFU) of virus. Virus titers in
ATCGATGAATTCTCTTCGAGCGAAAGCAGGTAGATA organs were determined 3 days after infection with
TTG-3* and 5*-GAGGACAAGCTTATTAACCCTCACTAA- MDCK cells (Bilsel et al., 1993).
AAGTAGAAACAAGGAGTTTTTTACT-3*. pUCT3PRM con- Analysis of M2 oligomerization. For the detection of
tains a T3 RNA polymerase promoter upstream and a M2 in virions, virus was grown in embryonated eggs,
Ksp632I site downstream of the M gene. This arrange- purified (Laver, 1969), and lysed in buffer (50 mM Tris,
ment allows the generation of viral sense RNA transcripts pH 6.8, 2% SDS, 0.01% Bromophenol blue, and 10% glyc-
when the plasmid is digested with Ksp632I, filled-in with
erol) for 5 min at 257. M2 oligomers were detected by
Klenow fragment, and transcribed with T3 RNA polymer-
Western blotting (Gallagher et al., 1993) with monoclonal
ase (Enami et al., 1990). pUCT3Cys17, pUCT3Cys19,
antibodies specific to M2 (Zebedee and Lamb, 1988),
pUCT3Cys50, and pUCT3Cys17-19-50 were constructed
after the viral proteins were fractionated (50 mg viral pro-by using oligonucleotide-directed mutagenesis (Kunkel
tein/well for purified virus) by 10% sodium dodecyl sul-et al., 1987) to replace the M gene nucleotides that trans-
fate–polyacrylamide gel electrophoresis (SDS–PAGE)late to Cys-17, Cys-19, and Cys-50, with nucleotides that
under reducing (in the presence 1% 2-mercaptoethanol)code for serine.
and nonreducing (in the absence of 2-mercaptoethanolNucleoprotein (NP) and polymerase (P) proteins were
and DTT) conditions.purified from A/duck/Alberta/35/76 (H1N1) by glycerol
Crosslinking. Stock solutions of dithiobis (succinimidyland glycerol-cesium chloride (CsCl) gradients as pre-
propionate) (DSP; 50 mg/ml) and ethylene glycolbis (suc-viously described (Parvin et al., 1989). An artificial M
cinimidyl succinate) (EGS; 10 mg/ml) were prepared inribonucleoprotein (RNP) complex was prepared by tran-
dimethylsulfoxide and added to purified virus at final con-scribing pUCT3PRM, pUCT3Cys17, pUCT3Cys19, pUCT-
centrations of 1 and 0.5 mg/ml, respectively. The samples3Cys50, and pUCT3Cys17-19-50 with T3 RNA polymer-
were incubated with the crosslinkers on ice for 30 minase in the presence of NP and P, after the plasmids had
before glycine was added to a final concentration of 60been digested with Ksp632I and filled-in with Klenow
mM. After crosslinking, an equal volume of 21 SDS–fragment, as described (Enami et al., 1990; Enami and
PAGE loading buffer was added to the samples, whichPalese, 1991). The M RNP complex was then transfected
were then loaded onto the gel.into 70–90% confluent MDBK cells that had been infected
Detection of M2 palmitylation. MDCK or Vero cells1 hr earlier with Eq/MIA at a multiplicity of infection of
were infected with virus (multiplicity of infection  10)1. Eighteen hours after transfection, MDCK cells were
for 1 hr before being washed with PBS, then incubatedinfected with transfectants in supernatant fluid con-
with MEM containing [3H]palmitic acid (500 mCi/ml; 50–taining amantadine (1 mg/ml). Three days later, viruses
60 Ci/mmol) for 5 hr, and finally lysed in buffer (50 mMin the supernatant were plaque-purified in MDCK cells
Tris–HCl, pH 6.8, 600 mM KCl, 0.5% Triton X-100) at 47three times in the presence of amantadine (1 mg/ml) and
for 10 min. Samples were then fractionated by 10% SDS–then inoculated into embryonated eggs. The M gene of
the viruses was sequenced as described (Katz and Web- PAGE under reducing conditions. Gels were fixed,
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treated for 1 h with En3Hance (Dupont), and exposed to
Kodak X-Omat film.
One-step growth and thermostability. One-step growth
of virus was analyzed by infecting MDCK cells with virus
(multiplicity of infection  1) and incubating the cells for
1 hr, before washing them three times with PBS. The
cells were then incubated with an antiserum to Eq/MIA
(G30 / 39; 1:100 dilution) to neutralize the virions that
were not internalized, and then incubated with media.
Virus in the supernatant was titrated in MDCK cells 4, 6,
8, 10, 12, and 14 hr after infection.
The thermostability of the viruses was compared by
incubating virus stocks at either 37 or 457 and titrating
their infectivity in MDCK cells 0, 2, 4, 8, and 16 hr after
incubation.
RESULTS
Generation of influenza viruses that contain M2 pro-
teins whose cysteine residues have been mutated. To
investigate whether the cysteine residues of M2 have a
role in virus replication, we created transfectant viruses
in which individual cysteine residues were mutated to
serine and a virus in which all three cysteines were
changed to serine. Mutants were selected by using
amantadine resistance, conferred by the M2 protein of
the PR8 strain, and amantadine-sensitive Eq/MIA as a
helper virus (Castrucci and Kawaoka, 1995). Approxi-
mately 50% of the plaques we obtained represented vi-
ruses with the transfected M gene. Rescue efficiency
was similar among all the viruses bearing mutations and
the virus bearing the wild-type PR8 M gene. The transfec-
tant viruses were plaque-purified three times in MDCK
cells in the presence of amantadine and then inoculated
FIG. 1. One-step growth curves of M2 cysteine mutants. MDCK cells
into embryonated eggs to make virus stocks. These were infected with virus (multiplicity of infection  1). At the indicated
transfectants were designated Eq/MIA-PR8M, for the vi- times after infection, the virus titer in the supernatant was determined.
Values presented are means of duplicate experiments.rus containing the parent PR8 M gene, and Cys-17, Cys-
19, Cys-50, and Cys-17-19-50 for the mutants. All of the
mutants, except Cys-50, contained only the M gene origi-
Cys mutants replicated as efficiently as the wild-type Eq/nated from transfected RNP. The Cys-50 mutant retained
MIA-PR8M virus, growing up to 107 PFU/ml in MDCKthe M gene of Eq/MIA. We, therefore, plaque-purified the
cells and producing plaques of approximately the sameCys-50 mutant three more times in MDCK cells in the
size as the wild-type viruses (3 mm in diameter in 2 days).presence of amantadine under conditions where only a
To further compare the growth of these viruses in tissuesingle plaque would be detected. This final plaque was
culture, we analyzed their one-step growth (Fig. 1). Nonegrown in embryonated eggs to make a stock virus that
of the mutants was growth-defective in MDCK cells com-did not contain detectable Eq/MIA M gene.
pared to the wild-type virus; in fact, Cys-17 and Cys-50Because the Cys-50 mutant was unlike the other mu-
produced a higher virus titer than did the wild-type virustant in that it retained the helper Eq/MIA M gene after
at 6 and 8 hr postinfection. We also examined the thermo-the initial plaque purification, we passaged the final Cys-
stability of these viruses at 37 and 457 and found no50 egg-grown stock virus three more times in MDCK
significant differences between the wild-type and the Cyscells in the absence of amantadine and sequenced its
mutant viruses (data not shown).M gene to ensure that the stock was not contaminated
To examine the effects of the mutations on virus repli-with the helper Eq/MIA M gene. We found no indication
cation in vivo, we infected ferrets with the mutant viruses.of the presence of the Eq/MIA M gene and no additional
All of the mutant viruses and the wild-type Eq/MIA-PR8Mmutations in the M gene of the Cys-50 mutant.
M2 Cys mutant viruses are not defective. All of the M2 virus grew well (Table 1). No appreciable difference in
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TABLE 1
Replication of M2 Cysteine Mutants in Ferretsa
Virus titer in nasal wash (Log10 PFU/ml)
Titers in
Virus individual ferrets Mean { SD
Wild-type 4.2, 4.3, 4.3 4.3 { 0.1
Cys-17 3.1, 3.5, 4.8 3.8 { 0.9
Cys-19 3.6, 3.8, 4.9 4.1 { 0.7
Cys-50 4.4, 4.5, 4.5 4.5 { 0.1
Cys-17-19-50 3.0, 3.5, 5.8 4.1 { 1.5
a Five-month-old ferrets (n  3) were infected intranasally with 1 ml
of virus [107 plaque-forming units (PFU)]. The animals’ nostrils were
washed out on day 3 with 1 ml of phosphate-buffered saline, pH 7.2,
and the virus in the nasal wash samples was titrated with MDCK cells.
FIG. 2. [3H]palmitic acid labeling of M2 cysteine mutants. Vero cellsreplication was observed among the viruses, although
were infected with virus (multiplicity of infection  10) and 4 hr later
we tested a relatively small number of ferrets and only labeled with 500 mCi [3H]palmitic acid for 5 hr. The cells were then
one time point. Because the Cys-17 and Cys-19 of the M2 lysed and the proteins fractionated on 10% SDS polyacrylamide gels,
under reducing conditions. PR8, wild-type virus with the PR8 M2; 17,protein are evolutionarily highly conserved, these results
a mutant with cysteine 17 replaced with serine; 19, a mutant withwere surprising. We, therefore, compared the replication
cysteine 19 replaced with serine; 50, a mutant with cysteine 50 replacedof the Cys-17-19-50 mutant with that of the wild-type virus
with serine; 17-19-50, a mutant with cysteines 17, 19, and 50 replaced
in sufficient mice to allow statistical analysis. There was with serine.
no statistical difference in the ability of either virus to
replicate in the lungs (P  0.5). However, in the nasal
cysteine mutants for palmitylation. The labeling experi-turbinates, the Cys-17-19-50 mutant replicated at a signif-
ments with [3H]palmitic acid in Vero cells showed thaticantly higher titer than did the wild-type (P  0.001)
Cys-50 and Cys-17-19-50 do not contain palmitic acid;(Table 2). The nucleotide sequences of the entire M
however, the other virus M2 proteins were palmitylatedgenes from the Cys-17-19-50 virus recovered from ferrets
(Fig. 2). The Cys-19 mutant migrated more slowly than the(one from each ferret; a total of two viruses) and from
Cys-17 mutant (Fig. 2) in some experiments for unknownmice (one from each mouse; a total of three viruses)
reasons (see also Fig. 3). Essentially identical resultswere identical to that of the stock virus. These findings
were obtained in MDCK cells (data not shown), althoughindicate that the cysteine residues in the M2 protein are
the exposure time required to detect [3H]palmitic acid-not essential for virus replication in vitro or in vivo and
labeled M2 proteins in Vero cells was at least five timesmay even inhibit virus replication in the upper respiratory
shorter than that in MDCK cells because M2 is overex-tract.
pressed in Vero cells (Lau and Scholtissek, 1995). OurPalmitylation of M2. Because previous studies demon-
finding that the Cys-50 virus and the wild-type Eq/MIA-strated that M2 Cys-50 is palmitylated, we examined M2
PR8M virus replicated equally well suggests that palmitic
acid in the M2 protein is not essential for virus replication
in vitro or in vivo.TABLE 2
Oligomerization of mutant M2 proteins. Because ex-
Comparison of Wild-Type Virus Replication and the Replication
pression studies have shown that mutations in the Cysof a Cys-17-19-50 Mutant in Micea
residues of M2 affect the stability of the M2 oligomer
Virus titers (Log10PFU/g) { SD (Holsinger and Lamb, 1991), we analyzed the oligomer-
ization of our M2 Cys mutants in virions. All of the M2
Virus Nasal turbinate Lung proteins on virions were identified by Western blotting
as proteins of approximately 15 kDa (Fig. 3A). UnderWild-type 1.80 { 1.0 5.59 { 0.77
nonreducing conditions (Fig. 3B), the A/Udorn/307/72Cys-17-19-50 3.65 { 0.36 5.65 { 0.41
(H3N2) M2 protein was detected mainly as tetramers,
a Six-week-old female Balb/c mice (n  10), anesthetized with me- while the wild-type PR8 M2 protein revealed two strong
thoxyflurane, were infected intranasally with 50 ml of virus (107 PFU). signals that corresponded to dimers and tetramers and
Virus titers in organs were determined 3 days after infection with MDCK
a third weaker signal that was presumably a trimer. Thecells. Statistical significance was calculated using Student’s t test and
presumed trimer was not detected in some experiments.the following values were obtained: nasal turbinate, P  0.001; lung,
P  0.5. In the Cys-17 and Cys-19 mutants, the majority of the
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FIG. 3. Oligomerization of M2 cysteine mutants. Purified viruses were lysed with buffer (50 mM Tris, pH 6.8, 2% SDS, 0.01% BPB, and 10% glycerol)
for 5 min at 257. M2 oligomers were detected by Western blotting with a monoclonal antibody specific to the M2 protein (14C2) (Zebedee and
Lamb, 1988) after the viral proteins (50 mg viral protein/well) had been separated by SDS–PAGE under reducing (A; in the presence of 1% 2-
mercaptoethanol) and nonreducing (B, C) conditions. For crosslinking M2 proteins (C), purified virus was incubated with DSP (1 mg/ml final
concentration) for 30 min on ice, at which time glycine (60 mM final concentration) was added to stop the reaction. After crosslinking, iodoacetamide
(50 mM final concentration) was added, followed by an equal volume of 21 SDS–PAGE loading buffer, and the samples were loaded on the gel.
PR8, wild-type virus with the PR8 M2; 17, a mutant with cysteine 17 replaced with serine; 19, a mutant with cysteine 19 replaced with serine; 50,
a mutant with cysteine 50 replaced with serine; 17-19-50, a mutant with cysteines 17, 19, and 50 replaced with serine.
M2 molecules were detected as dimers, whereas more growth. Although this result is striking, given the involve-
ment of disulfide bonds in the oligomerization of mem-tetramers than dimers were detected in Cys-50. The Cys-
17-19-50 mutant was unique in that its M2 proteins brane proteins, it does not necessarily mean that viruses
lacking cysteine residues in their M2 ectodomain are asformed predominantly monomers, although a few dimers
and tetramers were also detected. The crosslinker DSP competitive as wild-type viruses in nature. For example,
the Cys-17-19-50 mutant may be less stable than theapparently promoted greater detection of tetramer forma-
tion for wild-type PR8, Cys-17, and Cys-19 (Fig. 3C). For wild-type virus (although we did not find any significant
differences in thermostability between the wild-type andthe Cys-17-19-50 mutant, the use of the crosslinker in-
creased the proportion of dimers and tetramers, but also mutant viruses). Moreover, the evolutionary conservation
of Cys-17 and Cys-19 (Ito et al., 1991) supports theirproduced two molecular species that migrated between
the dimers and tetramers. One of them may be the trimer, functional importance despite the implication from the
assays used in this study that the function of these resi-but the other is unknown. A similar result was obtained
with another crosslinker, EGS (data not shown). These dues is of minor importance.
Unlike the wild-type, most of the Cys-17-19-50 M2 mol-findings suggest that although tetramers of the Cys-17-
ecules were found as monomers even in the presence19-50 mutant exist in virions, they do so at lower levels
of crosslinkers. This is an intriguing finding because thethan those of other M2 proteins examined here.
M2 protein functions as an ion channel (Pinto et al., 1992)Reactivity with monoclonal antibodies. Previous stud-
and oligomerization is likely to be critical for this function.ies of the A/Udorn/307/72 M2 indicated that substitution
How then, could the Cys-17-19-50 virus replicate in vivoof both Cys-17 and Cys-19 with serine results in a loss
as efficiently or better than the wild type? The simplestof the reactivity with the M2 monoclonal antibody 5H6
explanation is that the Cys-17-19-50 M2 proteins exist(Zebedee and Lamb, 1988). Therefore, we analyzed the
as oligomers in the virions, just as the wild-type mole-reactivity of our M2 Cys mutants with a panel of mono-
cules do, but they are not stable under the conditions ofclonal antibodies (5C4, 5H6, and 1F1) in a radioimmuno-
our oligomerization analysis and crosslinking is simplyassay. All of the monoclonal antibodies reacted with the
not efficient. Alternatively, a limited number of Cys-17-mutants and the wild-type PR8 M2 protein (data not
19-50 oligomers may be sufficient for ion channel activityshown), showing that the loss of 5H6 reactivity is not
and the protein’s other functions.universal for M2 proteins that lack the ectodomain resi-
Oligomerization is a prerequisite for many viral glyco-dues Cys-17 and Cys-19.
proteins to be transported out of the endoplasmic reticu-
lum (for review see Doms et al., 1993). It is not knownDISCUSSION
whether M2 proteins must oligomerize before they can
In this study, we have shown that the Cys residues of be transported from the endoplasmic reticulum to the
the M2 protein are dispensable for virus replication in Golgi apparatus. If they must be oligomerized, and in-
vitro and in vivo. In fact, a mutant that lacked all three deed the Cys-17-19-50 M2 molecules exist mainly as
Cys residues, Cys-17-19-50, replicated more efficiently monomers, then M2 molecules in virions are in a dy-
in the mouse nasal turbinate than did the wild-type virus. namic equilibrium between monomers and oligomers;
These results demonstrate that disulfide bonds and pal- for the Cys-17-19-50 mutant, this equilibrium is shifted
toward monomers. A similar dynamic equilibrium hasmitic acid in the M2 proteins are not essential for virus
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